Plan to end drug rebates adds protections to insurers

The Trump administration said the federal government would propose a risk-sharing system to reimburse health insurers for financial losses resulting from the proposed ban on certain rebates from the pharmaceutical industry in Medicare.

The solution based on most insurer losses could help prevent premiums from rising significantly as a result of changes to the reimbursement rules, while also increasing taxpayer accountability for cost overruns in the prescription drug program. Medicare.

…